A Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imaging

KO-JEN LIJois, RameshRameshJoisLichauco, Juan JavierJuan JavierLichaucoSantos Estrella, PaulPaulSantos EstrellaLlamado, Lyndon JohnLyndon JohnLlamadoThorat, Amit VilasAmit VilasThoratMahgoub, EhabEhabMahgoub2022-02-092022-02-092019-062198-6576https://scholars.lib.ntu.edu.tw/handle/123456789/593950Considering the progressive nature of axial spondyloarthritis (axSpA), it is important to determine whether tumor necrosis factor alpha (TNFα) inhibitors have an effect on early inflammatory and structural lesions detected using magnetic resonance imaging (MRI).enAdalimumab; Axial spondyloarthritis; Certolizumab; Etanercept; Golimumab; Infliximab; Lesions; Magnetic resonance imaging; Tumor necrosis factor inhibitor[SDGs]SDG3adalimumab; certolizumab pegol; etanercept; golimumab; infliximab; tumor necrosis factor inhibitor; Bath ankylosing spondylitis functional index; bibliographic database; disease course; disease duration; human; medication compliance; nuclear magnetic resonance imaging; population; practice guideline; priority journal; Review; sacroiliac joint; spondylarthritisA Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imagingreview10.1007/s40744-019-0141-y307887802-s2.0-85111784996WOS:000468096300002https://scholars.lib.ntu.edu.tw/handle/123456789/579054